Percutaneous Hemodialysis Fistula Creation

Abstract

Two devices have been recently introduced to the European Union and North American clinical practice that allow for percutaneous creation of autogenous hemodialysis fistulae (percutaneous arteriovenous fistulae [pAVFs]). Although there are many similarities between the devices, there are several important differences. The adoption of either or both technologies by an interventionalist may be determined by the individual's familiarity and preferences. Current and future outcomes will shape the acceptance and use of this technology. This review focuses on the similarities and differences between the devices, procedures, published outcomes to date, and their interpretation and other clinical considerations toward the initiation of a successful pAVF program.